Prostate international

· 1 paper in corpus
2020
doi:10.1016/j.prnil.2019.06.001 ·PMID:32257971

BackgroundLeuprorelin is a well-established treatment for prostate cancer (PCa); however, there is limited information on its use in Asian males. This review of English language publications between January 2000 and 2016 describes the outco…